1. Home
  2. TECX vs PACK Comparison

TECX vs PACK Comparison

Compare TECX & PACK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$30.02

Market Cap

549.5M

Sector

N/A

ML Signal

HOLD

Logo Ranpak Holdings Corp

PACK

Ranpak Holdings Corp

HOLD

Current Price

$7.34

Market Cap

556.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECX
PACK
Founded
2019
1972
Country
United States
United States
Employees
60
N/A
Industry
Containers/Packaging
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
549.5M
556.9M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
TECX
PACK
Price
$30.02
$7.34
Analyst Decision
Strong Buy
Buy
Analyst Count
5
3
Target Price
$75.20
$6.50
AVG Volume (30 Days)
132.7K
474.7K
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$395,000,000.00
Revenue This Year
N/A
$9.29
Revenue Next Year
N/A
$8.35
P/E Ratio
N/A
N/A
Revenue Growth
N/A
7.08
52 Week Low
$14.39
$3.22
52 Week High
$35.99
$7.81

Technical Indicators

Market Signals
Indicator
TECX
PACK
Relative Strength Index (RSI) 54.28 64.25
Support Level $27.31 $4.73
Resistance Level $31.39 N/A
Average True Range (ATR) 1.89 0.35
MACD 0.12 -0.02
Stochastic Oscillator 71.39 62.10

Price Performance

Historical Comparison
TECX
PACK

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About PACK Ranpak Holdings Corp

Ranpak Holdings Corp is a provider of environmentally sustainable, systems-based, product protection solutions for e-Commerce and industrial supply chains. The company offers a full suite of protective packaging systems and paper consumables. The group generates revenue by providing its PPS systems and paper consumables to customers, which include direct end-users and a network of exclusive paper packaging solution distributors, and by providing end-of-line automation systems that solve challenges, including optimization, customization, and efficiency. It has two segments, North America and Europe/Asia.

Share on Social Networks: